知搜-全球专利检索

  1. 登录
  2. 注册

搜索结果

37 条记录 (耗时 0.023 秒)

    WEB-BASED PLATFORM FOR ANALYZING LARGE-SCALE TOF-SIMS DATA AND METHOD THEREOF
    3.
    发明申请
    WEB-BASED PLATFORM FOR ANALYZING LARGE-SCALE TOF-SIMS DATA AND METHOD THEREOF 审中-公开
    用于分析大规模TOF-SIMS数据的基于WEB的平台及其方法

    公开(公告)号：US20130173170A1

    公开(公告)日：2013-07-04

    申请号：US13405147

    申请日：2012-02-24

    申请人： Tae Geol LEE ,  Dae Hee Hwang ,  So Jeong Yun ,  Ji Won Park

    发明人： Tae Geol LEE ,  Dae Hee Hwang ,  So Jeong Yun ,  Ji Won Park

    IPC分类号： G06F19/10

    CPC分类号： G16C20/90 ,  G16C20/20 ,  G16C20/70

    摘要： Disclosed is a web-based platform for analyzing large-scale TOF-SIMS data and a method thereof. The web-based platform for analyzing large-scale TOF-SIMS data according to the present invention comprises: a communication unit for providing a connected user terminal with a web page and receiving a file for analyzing the TOF-SIMS data from the user terminal via the provided web page; a processing unit for analyzing the TOF-SIMS data using the received file and providing the user terminal with information created based on a result of the analysis via the communication unit; and a storage unit for storing the information created based on the result of the analysis. Through the platform, the present invention may provide a web-based tool that can be used in an automated analysis method.

    摘要翻译： 公开了用于分析大规模TOF-SIMS数据的基于网络的平台及其方法。 用于分析根据本发明的大规模TOF-SIMS数据的基于web的平台包括：通信单元，用于向连接的用户终端提供网页，并且从用户终端接收用于从用户终端分析TOF-SIMS数据的文件， 提供的网页; 处理单元，用于使用接收到的文件分析TOF-SIMS数据，并且经由通信单元向用户终端提供基于分析结果创建的信息; 以及存储单元，用于存储基于分析结果创建的信息。 通过该平台，本发明可提供可用于自动分析方法中的基于网络的工具。

    SECONDARY BATTERIES COMPRISING EUTECTIC MIXTURE AND PREPARATION METHOD THEREOF
    7.
    发明申请
    SECONDARY BATTERIES COMPRISING EUTECTIC MIXTURE AND PREPARATION METHOD THEREOF 审中-公开
    包含保护性混合物的二次电池及其制备方法

    公开(公告)号：US20100021815A1

    公开(公告)日：2010-01-28

    申请号：US12309707

    申请日：2007-07-26

    申请人： Jae-Seung Oh ,  Byoung-Bae Lee ,  Ji-Won Park ,  Shin-Jung Choi ,  Jae-Duk Park

    发明人： Jae-Seung Oh ,  Byoung-Bae Lee ,  Ji-Won Park ,  Shin-Jung Choi ,  Jae-Duk Park

    IPC分类号： H01M10/26 ,  H01M6/04

    CPC分类号： H01M10/0564 ,  H01M10/0565 ,  H01M10/0566 ,  H01M10/0567 ,  H01M10/0568 ,  H01M10/0569 ,  H01M10/08 ,  H01M2300/0025 ,  Y02T10/7016

    摘要： Disclosed is a secondary battery comprising a cathode, an anode, a separator and an electrolyte, wherein the electrolyte comprises: (a) a eutectic mixture; and (b) a first compound reduced at a higher potential vs. lithium potential (Li/Li+) than the lowest limit of the electrochemical window of the eutectic mixture. The electrolyte uses a eutectic mixture in combination with an additive reduced in advance of the eutectic mixture upon the initial charge to form a solid electrolyte interface (SEI) layer. Therefore, the electrolyte can solve the problem of electrolyte decomposition occurring when using a eutectic mixture alone as an electrolyte for a battery, and thus can prevent degradation of the quality of a battery.

    摘要翻译： 公开了包括阴极，阳极，隔板和电解质的二次电池，其中电解质包括：（a）共晶混合物; 和（b）比共晶混合物的电化学窗口的最低极限更高的电位降低的锂离子电位（Li / Li +）的第一化合物。 电解质使用共晶混合物与在初始电荷下先于共晶混合物还原的添加剂组合以形成固体电解质界面（SEI）层。 因此，电解质可以解决当单独使用共晶混合物作为电池的电解质时发生电解质分解的问题，因此可以防止电池质量的劣化。

    PHARMACEUTICAL COMPOSITION CONTAINING WOGONIN AS AN ACTIVE INGREDIENT FOR PREVENTING OR TREATING ASTHMA
    9.
    发明申请
    PHARMACEUTICAL COMPOSITION CONTAINING WOGONIN AS AN ACTIVE INGREDIENT FOR PREVENTING OR TREATING ASTHMA 审中-公开
    含有WOGONIN的药物组合物作为预防或治疗哮喘的主要成分

    公开(公告)号：US20140228427A1

    公开(公告)日：2014-08-14

    申请号：US14122789

    申请日：2012-05-24

    申请人： Sei Ryang Oh ,  Kyung Seop Ahn ,  Hyeong Kyu Lee ,  Ha Young Jang ,  Ok-Kyoung Kwon ,  Jung Hee Kim ,  Ji Won Park ,  Doo-Young Kim

    发明人： Sei Ryang Oh ,  Kyung Seop Ahn ,  Hyeong Kyu Lee ,  Ha Young Jang ,  Ok-Kyoung Kwon ,  Jung Hee Kim ,  Ji Won Park ,  Doo-Young Kim

    IPC分类号： A61K31/352

    CPC分类号： A61K31/352

    摘要： The present invention relates to a pharmaceutical composition for the prevention or treatment of asthma comprising Wogonin as an active ingredient. The Wogonin of the present invention is excellent not only in relieving airway hypersensitivity that causes asthma in vivo, in inhibiting reactive oxygen species generation in the airway, and in inhibiting the infiltration of inflammatory cells in the bronchus, but also in inhibiting the generation of IgE in serum and bronchoalveolar lavage fluid, and in inhibiting the expressions of Th2 cytokines in the lung. Therefore, the Wogonin of the present invention can be effectively used as a composition for the prevention, treatment, or improvement of asthma.

    摘要翻译： 本发明涉及一种用于预防或治疗哮喘的药物组合物，其包含沃可素作为活性成分。 本发明的Wogonin不仅能缓解气道在体内引起哮喘，抑制气道中的活性氧产生，抑制炎症细胞在支气管中的浸润，而且抑制IgE的产生， 在血清和支气管肺泡灌洗液中，并抑制肺中Th2细胞因子的表达。 因此，本发明的沃可素可以有效地用作预防，治疗或改善哮喘的组合物。